Paweł Blecharz

Summary

Affiliation: Medical University
Country: Poland

Publications

  1. ncbi request reprint Prognostic factors in patients with carcinoma of the vulva--our own experience and literature review
    P Blecharz
    Center of Oncology, Gynecologic Oncology Department, M Sklodowska Curie Memorial Institute, Krakow Branch, Krakow, Poland
    Eur J Gynaecol Oncol 29:260-3. 2008
  2. ncbi request reprint Effectiveness of radiotherapy in patients with primary invasive vaginal carcinoma
    P Blecharz
    Gynaecologic Oncology Department, Centre of Oncology, Maria Sklodowska Curie Memorial Institute, Krakow Branch, Krakow, Poland
    Eur J Gynaecol Oncol 34:436-41. 2013
  3. ncbi request reprint Radiation therapy complications in patients with primary invasive vaginal carcinoma
    Paweł Blecharz
    Department of Gynecologic Oncology, Centre of Oncology, Maria Sklodowska Curie Memorial Institute, Krakow Branch, Poland
    Ginekol Pol 84:206-10. 2013
  4. doi request reprint Radiotherapy for carcinoma of the vagina. Immunocytochemical and cytofluorometric analysis of prognostic factors
    P Blecharz
    Department of Gynecologic Oncology, Center of Oncology Maria Skłodowska Curie Memorial Institute, Garncarska 11, 31 115 Krakow, Krakow, Poland
    Strahlenther Onkol 189:394-400. 2013
  5. ncbi request reprint Prognostic factors in patients with primary invasive vaginal carcinoma
    Paweł Blecharz
    Gynaecology Department, Centre of Oncology, Maria Sklodowska Curie Memorial Institute, Krakow Branch, Poland
    Ginekol Pol 83:904-9. 2012
  6. ncbi request reprint [Clinical features and disease course in patients with BRCA1-dependent ovarian cancer]
    Paweł Blecharz
    Klinika Ginekologii Onkologicznej Centrum Onkologii, Instytut im M Skłodowskiej Curie, Oddział Kraków, Polska
    Ginekol Pol 83:353-6. 2012
  7. ncbi request reprint Vaginal and pelvic recurrences in stage I and II endometrial carcinoma--survival and prognostic factors
    P Blecharz
    Center of Oncology, Gynecologic Oncology Department, M Skłodowska Curie Memorial Institute, Krakow, Poland
    Eur J Gynaecol Oncol 32:403-7. 2011
  8. ncbi request reprint [The prevalence of BRCA1 mutations among families at high-risk of breast and ovarian cancer in province of Malopolska between 2004-2009]
    Paweł Blecharz
    Klinika Ginekologii Onkologicznej, Centrum Onkologii, Instytut im M Skłodowskiej Curie, Oddział Kraków
    Przegl Lek 66:1046-8. 2009
  9. ncbi request reprint [Hereditary ovarian cancer. The role of BRCA1 gene dysfunction in response to chemotherapy]
    Paweł Blecharz
    Klinika Ginekologii Onkologicznej, Centrum Onkologii, Instytut im M Skłodowskiej Curie, Oddział Kraków, 31 115 Krakow, Polska
    Ginekol Pol 82:214-20. 2011
  10. doi request reprint Hematogenous metastases in patients with Stage I or II endometrial carcinoma
    Paweł Blecharz
    Department of Gynecologic Oncology, Center of Oncology Maria Skłodowska Curie, Memorial Institute, Krakow, Poland
    Strahlenther Onkol 187:806-11. 2011

Collaborators

Detail Information

Publications20

  1. ncbi request reprint Prognostic factors in patients with carcinoma of the vulva--our own experience and literature review
    P Blecharz
    Center of Oncology, Gynecologic Oncology Department, M Sklodowska Curie Memorial Institute, Krakow Branch, Krakow, Poland
    Eur J Gynaecol Oncol 29:260-3. 2008
    ..The objective was the analysis of prognostic factors and treatment outcomes of 104 patients with vulvar cancer, treated between 1990 and 2003 in the Center of Oncology, Maria Sklodowska-Curie Memorial Institute, Cracow, Poland...
  2. ncbi request reprint Effectiveness of radiotherapy in patients with primary invasive vaginal carcinoma
    P Blecharz
    Gynaecologic Oncology Department, Centre of Oncology, Maria Sklodowska Curie Memorial Institute, Krakow Branch, Krakow, Poland
    Eur J Gynaecol Oncol 34:436-41. 2013
    ....
  3. ncbi request reprint Radiation therapy complications in patients with primary invasive vaginal carcinoma
    Paweł Blecharz
    Department of Gynecologic Oncology, Centre of Oncology, Maria Sklodowska Curie Memorial Institute, Krakow Branch, Poland
    Ginekol Pol 84:206-10. 2013
    ..The aim of the study was to estimate acute and late complications of radiation therapy in primary invasive vaginal carcinoma (PIVC) patients...
  4. doi request reprint Radiotherapy for carcinoma of the vagina. Immunocytochemical and cytofluorometric analysis of prognostic factors
    P Blecharz
    Department of Gynecologic Oncology, Center of Oncology Maria Skłodowska Curie Memorial Institute, Garncarska 11, 31 115 Krakow, Krakow, Poland
    Strahlenther Onkol 189:394-400. 2013
    ..The aim of this study was to assess the potential prognostic factors in patients with primary invasive vaginal carcinoma (PIVC) treated with radical irradiation...
  5. ncbi request reprint Prognostic factors in patients with primary invasive vaginal carcinoma
    Paweł Blecharz
    Gynaecology Department, Centre of Oncology, Maria Sklodowska Curie Memorial Institute, Krakow Branch, Poland
    Ginekol Pol 83:904-9. 2012
    ..Aim of the study was the assessment of prognostic factors in the group of primary invasive vaginal carcinoma (PIVC) patients subjected to radical radiation therapy..
  6. ncbi request reprint [Clinical features and disease course in patients with BRCA1-dependent ovarian cancer]
    Paweł Blecharz
    Klinika Ginekologii Onkologicznej Centrum Onkologii, Instytut im M Skłodowskiej Curie, Oddział Kraków, Polska
    Ginekol Pol 83:353-6. 2012
    ..About 10% of cases is hereditary and BRCA1 gene mutation-dependant. Some authors claim that clinical features, the course of the disease and prognosis of BRCA1-dependent OC vary between sporadic cases...
  7. ncbi request reprint Vaginal and pelvic recurrences in stage I and II endometrial carcinoma--survival and prognostic factors
    P Blecharz
    Center of Oncology, Gynecologic Oncology Department, M Skłodowska Curie Memorial Institute, Krakow, Poland
    Eur J Gynaecol Oncol 32:403-7. 2011
    ....
  8. ncbi request reprint [The prevalence of BRCA1 mutations among families at high-risk of breast and ovarian cancer in province of Malopolska between 2004-2009]
    Paweł Blecharz
    Klinika Ginekologii Onkologicznej, Centrum Onkologii, Instytut im M Skłodowskiej Curie, Oddział Kraków
    Przegl Lek 66:1046-8. 2009
    ..Moreover, the presence of "founder effect" is characteristic for those families. The aim of this paper was analysis of the incidence of BRCA1 mutation among such families in province of Malopolska, Poland...
  9. ncbi request reprint [Hereditary ovarian cancer. The role of BRCA1 gene dysfunction in response to chemotherapy]
    Paweł Blecharz
    Klinika Ginekologii Onkologicznej, Centrum Onkologii, Instytut im M Skłodowskiej Curie, Oddział Kraków, 31 115 Krakow, Polska
    Ginekol Pol 82:214-20. 2011
    ..Thus, the process of DNA repair is defective. Currently new groups of drugs using the BRCA1 dysfunctions are being introduced into clinical practice...
  10. doi request reprint Hematogenous metastases in patients with Stage I or II endometrial carcinoma
    Paweł Blecharz
    Department of Gynecologic Oncology, Center of Oncology Maria Skłodowska Curie, Memorial Institute, Krakow, Poland
    Strahlenther Onkol 187:806-11. 2011
    ..The aim of this study was to present the characteristics, methods of treatment, and the survival of patients with hematogenous metastases from endometrial carcinoma, free from local and other distant recurrences...
  11. pmc Prognostic factors in Polish patients with BRCA1-dependent ovarian cancer
    Wiktor Szatkowski
    Department of Gynaecological Oncology, Centre of Oncology, Maria Skłodowska Curie Memorial Institute, Krakow Branch, ul Garncarska 11, 31 115 Krakow, Poland
    Hered Cancer Clin Pract 14:4. 2016
    ..There have been very few studies on treatment outcomes in Central and Eastern European patients with OC. The aim of this study was to analyse prognostic factors in Polish patients with BRCA1-dependent OC (BRCA1-OC)...
  12. doi request reprint Palliative thoracic radiotherapy for patients with advanced non-small cell lung cancer and poor performance status
    Tomasz Walasek
    Department of Radiation Oncology, Oncology Centre Maria Skłodowska Curie Memorial Institute Branch in Cracow, Poland, Garncarska 11, 31 115 Cracow, Poland
    Lung Cancer 87:130-5. 2015
    ..The evaluation of efficacy of palliative thoracic radiotherapy (PTR) in patients with advanced non-small cell lung cancer (NSCLC) and to compare it with efficacy of supportive care (SC) alone...
  13. ncbi request reprint Invasive lobular carcinoma of the breast: cytometric and immunohistochemical characteristics of 96 cases
    Piotr Skotnicki
    Department of Tumour Pathology, Maria Skłodowska Curie Memorial Institute, Krakow, Poland
    Pol J Pathol 63:112-20. 2012
    ....
  14. pmc Changes in the clinical characteristics, treatment options, and therapy outcomes in patients with phyllodes tumor of the breast during 55 years of experience
    Jerzy Władysław Mituś
    Department of Surgical Oncology, Centre of Oncology, Maria Skłodowska Curie Memorial Institute, Cracow Branch, Krakow, Poland
    Med Sci Monit 19:1183-7. 2013
    ..The aim of this work was to review these changes by analysis of consecutive patients with PT over a 55-year period at a single institution...
  15. doi request reprint Comparison of effectiveness of treatment of patients with sporadic and germline BRCA1-related ovarian cancer
    Wiktor Szatkowski
    Department of Gynecologic Oncology, Centre of Oncology, M Sklodowska Curie Memorial Institute, Cracow Department, Cracow, Poland
    Ginekol Pol 87:422-5. 2016
    ..Most of the authors indicate more fa-vourable treatment results in patients with BRCA1-OC. The aim of the study was to compare the effectiveness of treatment of patients with advanced-stage (FIGO III/IV) SOC and BRCA1-OC...
  16. pmc Current treatment options of brain metastases and outcomes in patients with malignant melanoma
    Jadwiga Nowak-Sadzikowska
    Oncology Clinic, Centre of Oncology, Maria Skłodowska Curie Memorial Institute, Cracow Branch, Krakow, Poland
    Rep Pract Oncol Radiother 21:271-7. 2016
    ..This review summarizes current treatment options, indications and outcomes in patients with brain metastases from melanoma. ..
  17. doi request reprint Palliative thoracic radiotherapy in non-small cell lung cancer. An analysis of 1250 patients. Palliation of symptoms, tolerance and toxicity
    Marian Reinfuss
    Department of Radiation Oncology, Center of Oncology Maria Sklodowska Curie Memorial Institute, Garncarska, Krakow, Poland
    Lung Cancer 71:344-9. 2011
    ....
  18. pmc Correlation between CT perfusion and clinico-pathological features in prostate cancer: a prospective study
    Elzbieta Łuczyńska
    Department of Radiology, Center of Oncology, M Skłodowska Curie Memorial Institute, Cracow, Poland
    Med Sci Monit 21:153-62. 2015
    ..The aim of the study was to assess the correlation between computed tomography perfusion (PCT) parameters and PSA levels, Gleason score, and pTNM stage in patients with prostate cancer (PCa)...
  19. ncbi request reprint Total number of lymph nodes and number of metastatic lymph nodes harvested during radical mastectomy did not influence early postoperative drainage volume
    Wojciech M Wysocki
    Department of Surgical Oncology, Maria Skłodowska Curie Memorial Institute of Oncology, Cancer Center, Krakow, Poland
    Ginekol Pol 84:696-9. 2013
    ..We also looked at the lymph node positivity (N+) and the number of metastatic axillary lymph nodes as a potential prognostic factors in this regard...
  20. ncbi request reprint The efficiency of treatment in patients with uterine-confined endometrial cancer
    K Karolewski
    Department of Gynecologic Oncology, Maria Sklodowska Curie Memorial Institute, Krakow, Poland
    Eur J Gynaecol Oncol 27:579-84. 2006
    ..To present our experience regarding the efficiency of treatment in patients with uterine-confined endometrial cancer...